These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 27256455)

  • 1. Assessment of in vitro COPD models for tobacco regulatory science: Workshop proceedings, conclusions and paths forward for in vitro model use.
    Behrsing H; Raabe H; Manuppello J; Bombick B; Curren R; Sullivan K; Sethi S; Phipps R; Tesfaigzi Y; Yan S; D'Ruiz C; Tarran R; Constant S; Phillips G; Gaça M; Hayden P; Cao X; Mathis C; Hoeng J; Braun A; Hill E
    Altern Lab Anim; 2016 May; 44(2):129-66. PubMed ID: 27256455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro exposure systems and dosimetry assessment tools for inhaled tobacco products: Workshop proceedings, conclusions and paths forward for in vitro model use.
    Behrsing H; Hill E; Raabe H; Tice R; Fitzpatrick S; Devlin R; Pinkerton K; Oberdörster G; Wright C; Wieczorek R; Aufderheide M; Steiner S; Krebs T; Asgharian B; Corley R; Oldham M; Adamson J; Li X; Rahman I; Grego S; Chu PH; McCullough S; Curren R
    Altern Lab Anim; 2017 Jul; 45(3):117-158. PubMed ID: 28816053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biomarkers of Potential Harm: Summary of an FDA-Sponsored Public Workshop.
    Chang CM; Cheng YC; Cho TM; Mishina EV; Del Valle-Pinero AY; van Bemmel DM; Hatsukami DK
    Nicotine Tob Res; 2019 Jan; 21(1):3-13. PubMed ID: 29253243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tobacco regulatory science: research to inform regulatory action at the Food and Drug Administration's Center for Tobacco Products.
    Ashley DL; Backinger CL; van Bemmel DM; Neveleff DJ
    Nicotine Tob Res; 2014 Aug; 16(8):1045-9. PubMed ID: 24638850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomarkers of Tobacco Exposure: Summary of an FDA-Sponsored Public Workshop.
    Chang CM; Edwards SH; Arab A; Del Valle-Pinero AY; Yang L; Hatsukami DK
    Cancer Epidemiol Biomarkers Prev; 2017 Mar; 26(3):291-302. PubMed ID: 28151705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Research on Youth and Young Adult Tobacco Use, 2013-2018, From the Food and Drug Administration-National Institutes of Health Tobacco Centers of Regulatory Science.
    Perry CL; Creamer MR; Chaffee BW; Unger JB; Sutfin EL; Kong G; Shang C; Clendennen SL; Krishnan-Sarin S; Pentz MA
    Nicotine Tob Res; 2020 Jun; 22(7):1063-1076. PubMed ID: 31127298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A critical assessment of the scientific basis, and implementation, of regulations for the safety assessment and marketing of innovative tobacco-related products.
    Combes RD; Balls M
    Altern Lab Anim; 2015 Sep; 43(4):251-90. PubMed ID: 26375889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nicotine Reduction Strategy: State of the science and challenges to tobacco control policy and FDA tobacco product regulation.
    Benowitz NL; Henningfield JE
    Prev Med; 2018 Dec; 117():5-7. PubMed ID: 29944901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. No sisyphean task: how the FDA can regulate electronic cigarettes.
    Paradise J
    Yale J Health Policy Law Ethics; 2013; 13(2):326-74. PubMed ID: 24340824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Understanding the Tobacco Control Act: efforts by the US Food and Drug Administration to make tobacco-related morbidity and mortality part of the USA's past, not its future.
    Husten CG; Deyton LR
    Lancet; 2013 May; 381(9877):1570-80. PubMed ID: 23642698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proceedings of the Second Workshop on Theory meets Industry (Erwin-Schrödinger-Institute (ESI), Vienna, Austria, 12-14 June 2007).
    Hafner J
    J Phys Condens Matter; 2008 Feb; 20(6):060301. PubMed ID: 21693862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The First 10 Years: Reflecting on Opportunities and Challenges of the Tobacco Products Scientific Advisory Committee of the United States Food and Drug Administration.
    Fagan P; Eissenberg T; Jones DM; Cohen JE; Nez Henderson P; Clanton MS
    J Leg Med; 2020; 40(3-4):293-320. PubMed ID: 33797324
    [No Abstract]   [Full Text] [Related]  

  • 13. Cigarette whole smoke solutions disturb mucin homeostasis in a human in vitro airway tissue model.
    Cao X; Wang Y; Xiong R; Muskhelishvili L; Davis K; Richter PA; Heflich RH
    Toxicology; 2018 Nov; 409():119-128. PubMed ID: 30053496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FDA's misplaced priorities: premarket review under the Family Smoking Prevention and Tobacco Control Act.
    Jenson D; Lester J; Berman ML
    Tob Control; 2016 May; 25(3):246-53. PubMed ID: 27068243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An evaluation of the FDA's analysis of the costs and benefits of the graphic warning label regulation.
    Chaloupka FJ; Warner KE; Acemoğlu D; Gruber J; Laux F; Max W; Newhouse J; Schelling T; Sindelar J
    Tob Control; 2015 Mar; 24(2):112-9. PubMed ID: 25550419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toward a comprehensive policy on nicotine delivery products and harm reduction.
    Solyst J
    Food Drug Law J; 2012; 67(4):393-404, i. PubMed ID: 24640613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ciliary Beat Frequency: Proceedings and Recommendations from a Multi-laboratory Ring Trial Using 3-D Reconstituted Human Airway Epithelium to Model Mucociliary Clearance.
    Behrsing HP; Wahab A; Ukishima L; Grodi C; Frentzel S; Johne S; Ishikawa S; Ito S; Wieczorek R; Budde J; Keyser BM; Haswell LE; Thorne D; Bishop E; Breheny D; Cao X; Qin Q; Patel V
    Altern Lab Anim; 2022 Jul; 50(4):293-309. PubMed ID: 35938181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Airway hydration and COPD.
    Ghosh A; Boucher RC; Tarran R
    Cell Mol Life Sci; 2015 Oct; 72(19):3637-52. PubMed ID: 26068443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deeming Tobacco Products To Be Subject to the Federal Food, Drug, and Cosmetic Act, as Amended by the Family Smoking Prevention and Tobacco Control Act; Restrictions on the Sale and Distribution of Tobacco Products and Required Warning Statements for Tobacco Products. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2016 May; 81(90):28973-9106. PubMed ID: 27192730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human Abuse Liability Assessment of Tobacco and Nicotine Products: Approaches for Meeting Current Regulatory Recommendations.
    Vansickel A; Baxter S; Sherwood N; Kong M; Campbell L
    Nicotine Tob Res; 2022 Feb; 24(3):295-305. PubMed ID: 34498698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.